Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Faraz Naqvi

Faraz Naqvi

individual
Fund operatorEcosystem influencer

About

Faraz Naqvi, MD is a physician-investor and biotech operator best known as Founder and Medical Director of Ambrosia Biosciences, a Boulder drug-discovery company focused on obesity and metabolic disorders. Earlier in his career he held senior healthcare investing roles at Crossover Partners, Avicenna Capital/Brevan Howard, Pequot Capital, Allianz-Dresdner Asset Management, and Bank of America Securities, with SEC-disclosed responsibility for multi-billion-dollar healthcare funds. He has also served on healthcare-related boards including UCHealth and the Health District of Northern Larimer County.

Areas of interest

biotechhealthcare investingmetabolic diseaseobesity therapeuticsdrug discoverygeriatric medicinedigital healthtelemedicine